Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
30-Second Chair Stand Test

Jan 9, 2015/Test & Measure

Primarily used for ages 60 and above.

Functional Reach Test for Multiple Sclerosis (MS)

Jan 25, 2015/Test & Measure

Functional Reach Test for Multiple Sclerosis (MS)

High-Level Mobility Assessment Tool (HiMAT) and HiMAT-Revised (HiMAT-R)

May 24, 2015/Test & Measure

This is an objective test of a variety of gait and mobility functions such as running, hopping, stair navigation, backward walking in patients with traumatic brain injury (TBI).

Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

May 22, 2017/Test & Measure

Assesses delirium among patients in the intensive care unit.

Comprehensive High-Level Activity Mobility Predictor (CHAMP)

Jan 7, 2016/Test & Measure

Measures high-level mobility in people with lower limb loss.

6-Minute Walk Test (6MWT) (applied to patients who have had lower extremity total joint replacement)

Aug 7, 2017/Test & Measure

Measures a patient's functional capacity by recording the distance ambulated during a 6 min duration.

Functional Assessment Staging of Alzheimer’s Disease (FAST)

May 24, 2017/Test & Measure

A functional scale that is used to assess stage of dementia in patients with Alzheimer's disease (AD).

Pain Assessment in Advanced Dementia (PAINAD)

May 24, 2017/Test & Measure

Objectively measures five common nonverbal pain expressions.

European Organisation for Research and Treatment of Cancer (EORTC): Quality of Life Questionnaire – 30 Core Questionnaire (QLQ-C30), Fatigue subscale

Sep 8, 2023/Test & Measure

The European Organisation for Research and Treatment of Cancer (EORTC): Quality of Life Questionnaire measures quality of life for people with a current or previous diagnosis of cancer.

Minnesota Living with Heart Failure Questionnaire (MLHFQ)

Jun 30, 2022/Test & Measure

This summary describes a 21-item self-assessment survey to assess the extent to which heart failure (HF) affects the patient’s activities of daily living and quality of life. The higher the score, the more severe the limitations.